The endothelin axis in cancer
- 1 January 2008
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 40 (8) , 1443-1451
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007
- 3LB ZD4054, a potent, specific endothelin A receptor antagonist, improves overall survival in pain-free or mildly symptomatic patients with hormone-resistant prostate cancer (HRPC) and bone metastasesEuropean Journal of Cancer Supplements, 2007
- Endothelin-1 promotes cell survival in renal cell carcinoma through the ETA receptorCancer Letters, 2007
- A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanomaInvestigational New Drugs, 2006
- Elevated plasma big ET‐1 is associated with distant failure in patients with advanced‐stage nasopharyngeal carcinomaCancer, 2006
- Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in VivoThe American Journal of Pathology, 2003
- Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cellsBritish Journal of Cancer, 2003
- The endothelin axis: emerging role in cancerNature Reviews Cancer, 2003
- Endothelin-1 Protects Ovarian Carcinoma Cells against Paclitaxel-Induced Apoptosis: Requirement for Akt ActivationMolecular Pharmacology, 2002
- The Endothelin System in Human GlioblastomaLaboratory Investigation, 2000